© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Diabetes
Inside Chronic Diseases: COVID-19 and Diabetes
February 10, 2021
Diabetes education has shifted from in-person classes to Zoom meetings.
Glucose Lowering Medications Less Likely Among Medicare Advantage Beneficiaries
February 01, 2021
Commercial health insurance plan enrollees are more likely to take glucose-lowering medications.
Majority of Diabetes Patients Would Adopt Remote Digital Monitoring
January 13, 2021
The findings are encouraging for future use of remote digital monitoring.
Digital Health App for Diabetes May Reduce Healthcare Costs
December 16, 2020
Digital health apps offer solutions to improve diabetes self-management.
AHA: Fauci Says Long-term Follow Up Needed to Understand COVID-19 Effects
November 18, 2020
Dr. Anthony Fauci addresses the American Heart Association Scientific Sessions.
After Setbacks, Good News for Sotagliflozin in Heart Failure, CKD
November 17, 2020
After an FDA denial and a lost sponsor, sotagliflozin shows it can cut cardiovascular events and possibly treat a form of heart failure that has no approved therapies.
AHA: Four in Five Heart Failure Patients Fit Criteria for Farxiga
November 13, 2020
The findings are the first in a series of six studies involving a registry supported by drug makers in the diabetes, cardiovascular, and heart failure space.
Flu Shots Are More Important Than Ever for People with Diabetes, ASCVD
October 14, 2020
Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.
Anti-VEGF Therapy for Diabetic Retinopathy Gets to the Root Cause
September 14, 2020
Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.